Table 1 Comparison of preoperative baseline data between the two groups
UCP | TSCP | t/χ2value | P-value | ||
|---|---|---|---|---|---|
Number of cases/ eyes | 14/14 | 14/14 | |||
Gender (M/F) | 10/4 | 8/6 | 0.622 | 0.430 | |
Age (\( \overline{\boldsymbol{x}} \)± s, years) | 62.71 ± 16.69 | 53.93 ± 14.32 | −1.495 | 0.147 | |
Baseline IOP (\( \overline{\boldsymbol{x}} \)± s, mmHg) | 43.36 ± 12.68 | 40.64 ± 10.97 | −0.607 | 0.549 | |
IOP Stratifi-cation | 21 < IOP ≤ 35 | 5 | 7 | 1.359 | 0.5069 |
35 < IOP ≤ 45 | 1 | 2 | |||
IOP > 45 | 8 | 5 | |||
Number of anti-glaucoma agents (\( \overline{\boldsymbol{x}} \)± s) | 2.29 ± 0.83 | 2.36 ± 0.74 | 0.240 | 0.812 | |
Type of primary disease before surgery | OAG | 4 | 3 | 0.286 | 0.963 |
ACG | 3 | 3 | |||
Secondary | 4 | 4 | |||
NVG | 3 | 4 | |||
Best-corrected visual acuity before surgery | No LP | 5 | 5 | 4.800 | 0.187 |
LP | 2 | 3 | |||
HM | 7 | 3 | |||
CF | 0 | 3 | |||